Celltrion Healthcare to sell ‘Herzuma’ in 7 European countries
Celltrion Healthcare is expanding the number of countries to sell ‘Herzuma(generic name: trastuzumab),’ an antibody biosimilar for the treatment of breast cancer and stomach cancer.
Celltrion Healthcare launched ‘Herzuma’ in Spain, Portugal, Netherlands, Austria and Island and started to sell th...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
